-
1
-
-
0022395896
-
The cefoperazone-sulbactam combination. in vitro qualities including β-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion tests
-
Jones RN, Barry AL, Thornsberry C, Wilson HW. The cefoperazone-sulbactam combination. In vitro qualities including β-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion tests. Am J Clin Pathol 1985;84:496-505.
-
(1985)
Am J Clin Pathol
, vol.84
, pp. 496-505
-
-
Jones, R.N.1
Barry, A.L.2
Thornsberry, C.3
Wilson, H.W.4
-
2
-
-
0018143694
-
CP-45,899, a β-lactamase inhibitor that extends the antibacterial spectrum of β-lactams: Initial bacteriological characterization
-
English AR, Retsema JA, Girard AE, Lynch JE, Barth WE. CP-45,899, a β-lactamase inhibitor that extends the antibacterial spectrum of β-lactams: initial bacteriological characterization. Antimicrob Agents Chemother 1978;14:414-9.
-
(1978)
Antimicrob Agents Chemother
, vol.14
, pp. 414-419
-
-
English, A.R.1
Retsema, J.A.2
Girard, A.E.3
Lynch, J.E.4
Barth, W.E.5
-
3
-
-
0345473750
-
Cefoperazone: A review of its antimicrobial spectrum, β-lactamase stability, enzyme inhibition, and other in vitro characteristics
-
Jones RN, Barry AL. Cefoperazone: a review of its antimicrobial spectrum, β-lactamase stability, enzyme inhibition, and other in vitro characteristics. Rev Infect Dis 1983;5 (suppl):S108-26.
-
(1983)
Rev Infect Dis
, vol.5
, Issue.SUPPL.
-
-
Jones, R.N.1
Barry, A.L.2
-
4
-
-
0025130207
-
In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermenters
-
Fass RJ, Gregory WW, D'Amato RF, Matsen JM, Wright DN, Young LS. In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermenters. Antimicrob Agents Chemother 1990;34:2256-9.
-
(1990)
Antimicrob Agents Chemother
, vol.34
, pp. 2256-2259
-
-
Fass, R.J.1
Gregory, W.W.2
D'Amato, R.F.3
Matsen, J.M.4
Wright, D.N.5
Young, L.S.6
-
5
-
-
0025025090
-
In vitro activities of ampicillin-sulbactam and cefoperazone-sulbactam against oxacillin-susceptible and oxacillin-resistant staphylococci
-
Barry AL, Jones RN. In vitro activities of ampicillin-sulbactam and cefoperazone-sulbactam against oxacillin-susceptible and oxacillin-resistant staphylococci. Antimicrob Agents Chemother 1990;34:1830-2.
-
(1990)
Antimicrob Agents Chemother
, vol.34
, pp. 1830-1832
-
-
Barry, A.L.1
Jones, R.N.2
-
6
-
-
0026565569
-
Multicentre study on antibiotic susceptibilities of anaerobic bacteria to cefoperazone-sulbactam and other antimicrobial agents
-
Clark RB, Bartelt MA, Chan EL, Dalton HP. Multicentre study on antibiotic susceptibilities of anaerobic bacteria to cefoperazone-sulbactam and other antimicrobial agents. J Antimicrob Chemother 1992;29:57-67.
-
(1992)
J Antimicrob Chemother
, vol.29
, pp. 57-67
-
-
Clark, R.B.1
Bartelt, M.A.2
Chan, E.L.3
Dalton, H.P.4
-
7
-
-
0020438088
-
Activity of cefoperazone and two β-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with β-lactamase production
-
Crosby MA, Gump DW. Activity of cefoperazone and two β-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with β-lactamase production. Antimicrob Agents Chemother 1982;22:398-405.
-
(1982)
Antimicrob Agents Chemother
, vol.22
, pp. 398-405
-
-
Ma, C.1
Gump, D.W.2
-
8
-
-
0021981410
-
Well controlled comparative clinical trial of sulbactam/cefopcrazone (SBT/CPZ) and cefotaxime (CTX) in the treatment of respiratory infections
-
Hara K, Saito A, Suzuyama Y, et al. Well controlled comparative clinical trial of sulbactam/cefopcrazone (SBT/CPZ) and cefotaxime (CTX) in the treatment of respiratory infections. Chemotherapy 1985;33:184-8.
-
(1985)
Chemotherapy
, vol.33
, pp. 184-188
-
-
Hara, K.1
Saito, A.2
Suzuyama, Y.3
-
9
-
-
0021275386
-
Significance of combination of sulbactam and cefoperazone in the treatment of complicated urinary tract infection
-
Kawada Y, Kanematsu M, Nishiura T, et al. Significance of combination of sulbactam and cefoperazone in the treatment of complicated urinary tract infection. Chemotherapy 1984;32 (suppl 4):625-6.
-
(1984)
Chemotherapy
, vol.32
, Issue.SUPPL. 4
, pp. 625-626
-
-
Kawada, Y.1
Kanematsu, M.2
Nishiura, T.3
-
10
-
-
0025248077
-
A randomized clinical study of cefoperazone and sulbactam versus gentamicin and clindamycin in the treatment of intra-abdominal infections
-
Jauregui LE, Appelbaum PC, Fabian TC, et al. A randomized clinical study of cefoperazone and sulbactam versus gentamicin and clindamycin in the treatment of intra-abdominal infections. J Antimicrob Chemother 1990;25:423-33.
-
(1990)
J Antimicrob Chemother
, vol.25
, pp. 423-433
-
-
Jauregui, L.E.1
Appelbaum, P.C.2
Fabian, T.C.3
-
11
-
-
0025738294
-
Clinical experience with cefoperazone/sulbactam in critical surgical infection
-
Engin A, Mentes B, Turet S. Clinical experience with cefoperazone/sulbactam in critical surgical infection. Curr Ther Res 1991;49:989-97.
-
(1991)
Curr Ther Res
, vol.49
, pp. 989-997
-
-
Engin, A.1
Mentes, B.2
Turet, S.3
-
12
-
-
0023640807
-
Effect of β-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic β-lactamase producing bacteria
-
Fuchs PC, Jones RN, Barry AL. Effect of β-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic β-lactamase producing bacteria. Diagn Microbiol Infect Dis 1987;8:61-5.
-
(1987)
Diagn Microbiol Infect Dis
, vol.8
, pp. 61-65
-
-
Fuchs, P.C.1
Jones, R.N.2
Barry, A.L.3
|